University of Miami Sylvester Comprehensive Cancer Center

1475 NW 12th Avenue, Miami, Florida 33136

University of Miami Health System has a leading cancer center in South Florida: the University of Miami Sylvester Comprehensive Cancer Center. This center is the only one in the region with mesothelioma specialists offered to patients.

doctor image

focus icon

Pleural Mesothelioma and

Peritoneal Mesothelioma

location icon

University of Miami Sylvester Comprehensive Cancer Center

1475 NW 12th Avenue

Miami, Florida

specialist icon

Dr. Mecker Möller

Dr. Nestor Villamizar

doctor image

JUMP TO A TOPIC

jump to icon

SCROLL TO TOP


More About Mesothelioma Treatment at University of Miami Cancer Center

University of Miami Sylvester Comprehensive Cancer Center is designated as a top medical facility by the National Cancer Institute. Only a select few cancer centers receive recognition from the NCI. University of Miami Sylvester is one of just two NCI-designated centers in Florida.

Dr. Mecker Möller leads peritoneal mesothelioma care at University of Miami Comprehensive Cancer Center. There are also thoracic surgeons able to see patients with pleural mesothelioma. The lead thoracic surgeon for mesothelioma is Dr. Nestor Villamizar.

“We need a team,” Dr. Möller said in an interview with Mesothelioma Guide. “That team requires the medical oncologists, surgical nutritionist, psychiatrist, palliative care team, ICU team, expert nurses and more.”

University of Miami’s cancer center sees nearly 20 cases of peritoneal mesothelioma each year. Dr. Möller points to a surge in female cases.

Cancer Center Specialists Icon

Experienced Mesothelioma Specialists

    • Dr. Mecker Möller, surgical oncologist
    • Dr. Nestor Villamizar, thoracic surgeon
    • Dr. Estelamari Rodriguez, thoracic medical oncologist
    • Dr. Agustin Pimentel, medical oncologist
    • Dr. Nkiruka Ezenwajiaku, medical oncologist
    • Dr. Alan Dal Pra, radiation oncologist
Cancer Center Affiliations Icon

Affiliations

    • University of Miami Sylvester Comprehensive Cancer Center
    • University of Miami Miller School of Medicine
Cancer Center Treatments Icon

Treatment Specialties

    • Cytoreductive/HIPEC surgery
    • Immunotherapy
    • Chemotherapy
    • Radiation
    • Tumor treating fields therapy (Optune Lua)

Get Connected to University of Miami Health

Get Connected to University of Miami Health - Form Image

University of Miami Sylvester Health System offers a wide range of mesothelioma care options, from palliative services to aggressive HIPEC surgery, through the cancer center. Dr. Mecker Möller is the lead specialist for peritoneal mesothelioma.

Why Choose University of Miami?

  • Specialists for mesothelioma on staff
  • Only mesothelioma cancer center in South Florida
  • High volume of peritoneal mesothelioma cases








Diagnosis:


Ready to Perform Surgery for Patients

Around half of cases are eligible for HIPEC surgery for peritoneal mesothelioma, and Dr. Möller said she performs on average one each month. That high of a case volume is important, especially when few hospitals offer this level of care for mesothelioma.

“This is a niche,” Dr. Möller said. “There aren’t many doctors doing this. I think patients benefit when you have all the medical care in one place and I’m glad we can do that here.”

“We make sure the patient sees the palliative care team, surgical nutrition team and many others.”

Protocol Before and Beyond Surgery

Aside from HIPEC surgery, University of Miami Sylvester offers immunotherapy, neoadjuvant chemotherapy and more. Dr. Möller said she sees “significant responses” from immunotherapy, pointing to further use in peritoneal mesothelioma.

“We are very passionate about making sure we provide patients with proper care,” Dr. Möller said. “We have a program in place to provide state-of-the-art treatment. … This isn’t one person. This requires a whole team. We treat patients, as a person, not just treating the disease. We are with them through this entire journey.”

Even for patients who can’t have aggressive surgery or are diagnosed in later stages, University of Miami Sylvester has care options available.

“You can switch from curative intent to palliative intent,” Dr. Möller said. “When you have an extensive tumor in the small bowel, you know you’ll have a less successful cytoreduction.

“You know HIPEC probably won’t be effective. So your debulking goes from curative debulking to palliative debulking. … You’re trying to slow down the disease.”

Cancer Center Ranking Icon

Hospital Ranking

    • Not listed in the U.S. News & World Report 2022-2023 Hospitals Honor Roll
    • Ranked 2nd in Miami
    • Ranked 48th for cancer treatment in general

Clinical Trials Offered at University of Miami Cancer Center

The hospital hosts numerous clinical trials for mesothelioma. Some are advanced trials testing life-saving approaches or therapies.

An example is the multicenter trial featuring intraoperative radiation therapy for pleural mesothelioma. This study has 22 locations and room for up to 150 participants. University of Miami Sylvester is enrolling patients.

How to Begin Treatment at University of Miami Health System

We can help you or a loved one begin receiving mesothelioma care at University of Miami Health System’s cancer hospital. The first step is contacting our staff at Mesothelioma Guide.

Patient advocate Karen Ritter is a registered nurse who understands the best way to contact cancer center staff, including specialists. She’ll help you schedule a consultation and take the first actions toward getting treatment at an NCI-designated cancer center.

Email karen@mesotheliomaguide.com for direct contact with Karen, or fill out a cancer center recommendation form to allow us time to find options for hospitals you can go to.

Sources & Author

    1. Mecker Moller, MD. University of Miami Health System. Retrieved from: https://doctors.umiamihealth.org/provider/Mecker+Moller/525248?_ga=2.38392163.1713037506.1638712475-78440731.1637072247. Accessed: 12/05/2021.
    2. Nestor Ricardo Villamizar, MD. University of Miami Health System. Retrieved from: https://sylvester-doctors.umiamihealth.org/provider/Nestor+Ricardo+Villamizar/525395?_ga=2.146866487.1883385217.1644024165-78440731.1637072247. Accessed: 02/04/2022.
    3. Alan Dal Pra, MD. University of Miami Health System. Retrieved from: https://sylvester-doctors.umiamihealth.org/provider/Alan+Dal+Pra/527356?unified=mesothelioma&_ga=2.146866487.1883385217.1644024165-78440731.1637072247&from=search-list. Accessed: 02/04/2022.
    4. Estelamari Rodriguez, MD, MPH. University of Miami Health System. Retrieved from: https://sylvester-doctors.umiamihealth.org/provider/Estelamari+Rodriguez/1257821?unified=mesothelioma&_ga=2.146866487.1883385217.1644024165-78440731.1637072247&from=search-list. Accessed: 02/04/2022.
    5. Hyperthermic Intraperitoneal and Intrapleural Chemotherapy (HIPEC) Program. University of Miami Health System. Retrieved from: https://umiamihealth.org/en/sylvester-comprehensive-cancer-center/treatments-and-services/hyperthermic-intraperitoneal-and-intrapleural-chemotherapy. Accessed: 12/05/2021.
    6. UMHC-Sylvester Comprehensive Cancer Center. U.S. News & World Report. Retrieved from: https://health.usnews.com/best-hospitals/area/fl/university-of-miami-hospital-and-clinics-6390610, Accessed: 02/04/2022.
    7. Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma. Clinical trials.gov. Retrieved from: https://clinicaltrials.gov/ct2/show/NCT04158141. Accessed: 02/04/2022.
Karen image

About the Writer, Karen Ritter, RN BSN

Karen Ritter, a registered nurse, is the lead patient advocate for Mesothelioma Guide. She has a deep passion for patient care, which includes helping patients and their families search for treatment options at the top mesothelioma cancer centers. She finds the balance between encouraging patients to receive the best treatment possible while enjoying their time with loved ones and friends. Karen is a valuable asset for patients due to her knowledge of mesothelioma, compassion for the victims of this disease and dedication to guiding patients through their treatment journey.